Statistics

Total Visits

Views
Bevacizumab plus capecitabine and oxaliplatin (XELOX) as first-line treatment for elderly patients with metastatic colorectal cancer (mCRC) suitable for combination chemotherapy: Efficacy and safety findings from the phase II BECOX study (GEMCAD Study Gro13

Select a period of time:

Number of views in the range

Views
Bevacizumab plus capecitabine and oxaliplatin (XELOX) as first-line treatment for elderly patients with metastatic colorectal cancer (mCRC) suitable for combination chemotherapy: Efficacy and safety findings from the phase II BECOX study (GEMCAD Study Gro6

Views

Views
May 20240
June 20242
July 20241
August 20242
September 20240
October 20240
November 20241
Download CSV file
 untranslated
 untranslated

Top country views

Views
United Kingdom3
United States3
 

Top cities views

Views
Chicago1